CD19 and acute lymphoblastic leukemia: Hence, the intrinsic cytotoxicity of these cells are redirected towards CD5+ T cell acute lymphoblastic leukemia (T-ALL) cell lines (although such antitumor activity is much weaker when compared to CD19-NSCAR γδ T cells against CD19+ B-ALL cell lines) (96).